ArticleInternational journal of nanomedicine2020

Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.

Alaa Mohamed Nazief et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.